Return to list

Deepening Industry–Academia–Research Collaboration to Jointly Craft a New Blueprint – A Report on the Visit by Leaders of Henan Normal University on March 8

2026-03-14

           3 Month On [Date], Nie Guoxing, Member of the Standing Committee of the Party Committee and Vice President of Henan Normal University, led a delegation including Chen Jianjun, Dean of the School of Life Sciences, and Jiang Yuqin, Vice Dean of the School of Engineering, to Zhongjie Pharmaceutical for an on-site research visit, engaging in in-depth discussions on university‑enterprise and university‑local cooperation initiatives. Li Yi, Deputy County Magistrate and Head of the Publicity Department, along with relevant leaders from the County Market Supervision Administration and Zhaipo Town, accompanied the delegation throughout the visit. Mark Guang, Chairman of the company, extended a warm welcome and provided full support throughout the entire tour.

The research team visited the company’s Intelligent Operations and Dispatch Center, Intelligent Production Workshop, and other core areas, conducting on-site inspections to assess the enterprise’s level of intelligent and digital transformation as well as the progress of its technology R&D. Chairman Ma Ke Guang provided a detailed report and explanation to the research team, focusing on key areas such as production process standardization, breakthroughs in new drug R&D, technological innovation, and the commercialization of scientific research outcomes. At present, Zhongjie Pharmaceutical has fully promoted and applied intelligent and automated technologies, achieving dynamic monitoring across the entire production process and precise optimization of critical process parameters. This has provided solid technical support for efficient energy allocation, cost control in production, and enhanced production efficiency, successfully driving the company’s production model toward greater precision and higher efficiency while demonstrating strong technological innovation capabilities and robust potential for high‑quality development.

         During the symposium, both sides engaged in in-depth discussions and candid exchanges on core issues such as talent development, technological innovation, and the commercialization of scientific and technological achievements. In his speech, Chairman Ma Guanguang stated that Zhongjie Pharmaceutical is currently at a critical stage of high‑quality development, with an increasingly urgent need for high‑end, specialized talent—especially in core areas like drug R&D and intelligent manufacturing. He emphasized the pressing need for universities to leverage their strengths in talent and research to provide robust support. He expressed his hope that this visit would serve as an opportunity to establish long‑term, stable university–enterprise partnerships, fostering resource sharing and complementary advantages.

         Vice President Nie Guoxing expressed high appreciation for Zhongjie Pharmaceutical’s development achievements and technological prowess. He stated that Henan Normal University has accumulated strong research capabilities in fields such as life sciences and pharmacy, boasting abundant talent resources and outstanding educational outcomes. The university will precisely align with Zhongjie Pharmaceutical’s development needs, actively explore areas of mutual cooperation, focus on establishing long‑term, stable strategic partnerships, deepen the integration of industry, academia, and research, accelerate the translation of scientific research findings into real productive forces, and help the company achieve transformation and upgrading, enhance quality and efficiency, ultimately realizing mutually beneficial, win‑win collaboration and coordinated development between the university and the enterprise.

        This research and field visit not only established a solid bridge for communication and collaboration between universities, enterprises, and local governments, but also explored new models and pathways for collaborative development. It plays a crucial role in deepening the integration of industry, academia, and research, accelerating the application and commercialization of scientific and technological achievements, and supporting the high‑quality development of the regional pharmaceutical industry. Looking ahead, Zhongjie Pharmaceutical will continue to adhere to a development strategy that balances organic growth with external expansion, leveraging… One Body, Two Wings ”  Develop a new development paradigm, firmly seize the opportunities presented by the times, and under the guidance and support of government departments and the research expertise of universities, continuously deepen the implementation of industry–university–research collaboration outcomes, accelerate the commercialization and application of scientific and technological achievements, and wholeheartedly promote high‑quality enterprise development—working hand in hand with all parties to write a new chapter of win‑win development in the pharmaceutical industry!

                                        
                                         Henan Zhongjie Pharmaceutical Co., Ltd. – Work Will announce

March 11, 2026 Day

Previous page:

Real-time news